Favipiravir CAS 259793-96-9 T-705 Purity ≥99.0% (HPLC) COVID-19 API Hoobkas Zoo
Chaw tsim tshuaj paus nrog High Purity thiab ruaj khov zoo
Kev Lag Luam Kev Lag Luam Favipiravir thiab Lwm Tus Neeg Nruab Nrab:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
Tom ntej: 3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
Tom ntej: 3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
Tom ntej: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
Tom ntej: 3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Tshuaj npe | Favipiravir |
Synonyms | T-705;6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide |
CAS Nr | 259793-96-9 |
CAT Number | RF-API 18 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale nce mus txog pua pua ntawm Kilograms |
Molecular Formula | C5H4FN3O2 |
Molecular Luj | 157.1 ib |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb rau Off-White Powder |
ID 1H-NMR | Raws li cov qauv npaj |
Kev txheeb xyuas HPLC | Lub sij hawm khaws cia ntawm lub ntsiab ncov hauv cov qauv kev npaj yuav tsum sib haum nrog lub sijhawm khaws cia ntawm lub ntsiab ncov hauv kev siv cov qauv kev npaj |
Kev Taw Qhia Mass | Pawg Spectrum zoo ib yam nrog cov qauv npaj |
Melting Point | 188.0 ℃ -193.0 ℃ |
Yam khoom muaj feem (Area Normalization) | Ib qho Impurity: ≤0.10% (HPLC) |
Tag nrho cov impurities: ≤1.0% (HPLC) | |
Purity / Analysis Method | ≥99.0% (HPLC) |
Moisture (KF) | ≤0.50% |
Residue ntawm Ignition | ≤0.10% |
Hnyav Hlau | ≤ 20ppm |
Residue Solvents | |
Methanol | ≤3000ppm |
Isopropanol | ≤5000ppm |
n-Heptane | ≤5000ppm |
Ethanol | ≤5000ppm |
Test Standard | Enterprise Standard |
Kev siv | Cov khoom xyaw tshuaj nquag (API);Kev kho mob ntawm COVID-19 |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.
Favipiravir (T-705) (CAS 259793-96-9) yog ib qho ntawm 5 lub tebchaw pom zoo los ntawm WHO rau kev tshawb nrhiav kev kho mob ntawm COVID-19.Favipiravir yog ib qho kev xaiv inhibitor ntawm tus kab mob RNA-dependent RNA polymerase nrog kev ua haujlwm tawm tsam ntau tus kab mob RNA, kab mob khaub thuas, kab mob West Nile, tus kab mob daj daj, kab mob ko taw thiab qhov ncauj thiab lwm yam flaviviruses, arenaviruses, bunyaviruses thiab alphaviruses.Favipiravir yog cov tshuaj tiv thaiv kab mob dav dav uas tau raug tshem tawm los ntawm Cov Tshuaj Tswj Xyuas Tshuaj General ntawm Is Nrias teb (DCGI) lub lim tiam dhau los rau "kev txwv xwm txheej ceev" siv ntawm Covid-19 cov neeg mob.Favipiravir yog thawj zaug tsim nyob rau hauv lub lig 1990s los ntawm ib lub tuam txhab uas tau tom qab yuav los ntawm Nyiv lub tuam txhab Fujifilm ua ib feem ntawm nws txoj kev hloov ntawm kev lag luam yees duab mus rau kev kho mob.Tom qab tau sim tawm tsam ntau yam kab mob, cov tshuaj tau pom zoo hauv Nyij Pooj xyoo 2014 rau kev siv thaum muaj xwm txheej ceev tiv thaiv kab mob khaub thuas lossis kho kab mob khaub thuas tshiab.